Promising COVID-19 vaccine candidate from Slovakian biotech company AXON Neuroscience
AXON Neuroscience, a clinical-stage biotech company and an industry leader in treating and preventing neurodegenerative diseases, is developing a promising vaccine candidate against COVID-19. Based in Bratislava, Axon has over 20 years of experience in development of safe and immunogenic peptide vaccines. Its well-established scalable technology enabled the company to join quickly the global race...